Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Medical Devices

GE Healthcare, Giraffe OmniBed and Giraffe Incubator

Recall Class: Class I

Date Recall Initiated: January 8, 2013

Products: Giraffe OmniBed and Giraffe Incubator

Serial Numbers: To locate the serial numbers of affected products, refer to FDA’s Class I Recall information.

These products were manufactured and distributed from August 01, 2012 to December 01, 2012.

Use: The Giraffe OmniBed can function as an incubator (closed mode) or as a warmer (open mode) and can transition from one mode to the other on the user’s demand. Incubators and warmers are used to maintain the body temperature of a newborn baby. In “closed mode”, the OmniBed provides heat through a closed, temperature-controlled environment. In “open mode”, the device provides heat in an open environment using overhead heaters.

The Giraffe Incubator is an infant incubator used to maintain the body temperature of a newborn baby by providing heat through a closed, temperature-controlled environment. This device may include a controlled oxygen delivery system that is used to provide stable amounts of oxygen to newborn babies.

Recalling Firm:
GE Healthcare, LLC
9900 Innovation Drive
Waukesha, Wisconsin 53226

Reason for Recall:
The Giraffe Incubator and Giraffe OmniBed may randomly delete stored information and enter new information in its place (over-write) when the device turns “on” or recovers from a power failure. When this occurs, the heater or oxygen delivery option will turn “off” and the new set point will be “0”. In addition, alarms may not appropriately alert users that heater or oxygen delivery options are “off” or that the set points are less than intended. The alarm failure may go unnoticed.

All newborn babies using this device are at risk of serious adverse health consequences, including death, due to this malfunction. Inaccurate temperature can result in hypothermia (dangerously low body temperature) or hyperthermia (dangerously high body temperature), and inaccurate oxygen regulation can result in hypoxia (low blood oxygen) or hyperoxia (high blood oxygen). In addition, newborn babies requiring transport may be at increased risk of adverse health consequences due to potential malfunction when moving from one power source to another (wall outlet to/from battery power).

Public Contact: Customers with questions can call GE Healthcare’s Customer Service line at 1-800-345-2700 (24 hours a day, 7 days a week).

FDA District: Baltimore District Office

FDA Comments:
On January 8, 2013, GE Healthcare sent "Urgent Medical Device Correction" letters to affected customers notifying them of the problem, the affected devices, and the action to be taken by the customer. In addition, customers were given instructions for continued use of the Giraffe OmniBed and Giraffe Incubators. GE Healthcare will correct all affected devices at no cost, and will contact customers to arrange for this correction.

Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX.

Additional Links:

Page Last Updated: 07/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English